Column

Global Newsletter

Latin America, a region of opportunities to conduct Clinical Trials.

One of the continents that has been gaining more relevance for clinical trials in recent times has been Latin America, but to better understand this market let's start with some relevant data.

• LatinAmerica
• Market

Global Newsletter

Volume of importing medical devices and updated medical device regulations in Thailand

According to the Plastic Institute of Thailand, Thailand's medical device imports grew by about 23% in the 2Q of 2021. And is expected to average 6.5% per year due to the aging of the population, rising demand for healthcare.

• Thailand
• Medical Equipment
• Laws

Global Newsletter

Orphan Drugs and Rare Diseases in Asia.

Development of orphan drugs is often difficult to get off the ground due to the cost of manufacturing the drugs and the risk of sales. However, in Asia, many patients seeking treatment, even for very rare diseases.

• Market
• Laws
• Approval

Regenerative Medicine Column

ISSCR Special Edition:Regenerative Medicine and list of Regenerative Medicine Products Approved in Japan

This article is a special edition of the Regenerative Medicine Column distributed at the ISSCR Tokyo International Symposium 2021 held in October 2021. It introduces Remedy's Approach to Regenerative Medicine and list of Regenerative Medicine Products Approved in Japan.

• Regenerative Medicine Product
• Laws
• Product

Regenerative Medicine Column

Conditions for use of regenerative medicine products and specified medical care coverage system for clinical trials

In this article, we will explain the conditions under which regenerative medicine can be applied to treatment, as well as the system of uninsured concomitant therapy expenses for clinical trials.

• Clinical Trials
• Insurance System
• Laws

Regenerative Medicine Column

Gene therapy using genome editing technology– Noticeable CAR-T cells

Genome editing has become widely known since the CRISPR/Cas9 system won the Nobel Prize in Chemistry. What is “gene therapy using genome editing technology”? Also, what are CAR-T cells, which are attracting attention?

• Treatment and Technology
• New Trends
• Genes